Travere Therapeutics Inc. – Underwriting Agreements

NASDAQ: TVTX
Share price (9/29/26): $59.99
Market cap (9/29/26): $5.655 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from 8-K 48 pages $475,000,000 0.50% Convertible Senior Notes Due 2032 Travere Therapeutics, Inc. Underwriting Agreement

from 8-K 46 pages 7,812,500 Shares Travere Therapeutics, Inc. Underwriting Agreement

from 10-Q 43 pages Amended & Restated Open Market Sale Agreementsm

from 8-K 47 pages 8,275,000 Shares Pre-Funded Warrants to Purchase 1,250,000 Shares Travere Therapeutics, Inc. Underwriting Agreement

from 8-K 35 pages $275,000,000 2.25% Convertible Senior Notes Due 2029 Travere Therapeutics, Inc. Underwriting Agreement

from SC 13G/A 1 page Agreement

from 8-K 38 pages 6,550,000 Shares Travere Therapeutics, Inc. Underwriting Agreement

from 8-K 46 pages 6,500,000 Shares Retrophin, Inc. Underwriting Agreement

from 10-K 35 pages Open Market Sale Agreementsm

from 8-K 40 pages $240,000,000 2.50% Convertible Senior Notes Due 2025 Retrophin, Inc. Underwriting Agreement

from 8-K 36 pages 6,840,000 Shares Retrophin, Inc. Common Stock, Par Value $0.0001 Per Share Underwriting Agreement

from S-1/A 41 pages 4,820,000 Shares Retrophin, Inc. Underwriting Agreement

from SC 13D ~1 page Joint Filing Agreement